Charles River forecasts upbeat 2026 profit on improved demand for drug development services

Charles River forecasts upbeat 2026 profit on improved demand for drug development services | ReutersSkip to main content[Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv]- Companies[Charles River Laboratories International Inc]FollowFeb 18 (Reuters) - Contract drug developer Charles River Laboratories [(CRL.N), opens new tab] on Wednesday forecast annual profit above Wall Street estimates, betting on an improvement in demand for its drug discovery and developme ...